CD8+ T cells have the ability to recognize tumor associated antigens (TAA) with major histocompatibility complex (MCH) class I, producing IFN-γ, and inducing cell cycle inhibition, apoptosis and macrophage tumoricidal activity (Mahmoud et al., 2011). The gene discussed is IFNG; the disease is neoplasm.